Triangle medtechs earn spots in prestigious MTI Accelerator Cohort featuring OsteoCure Therapeutics and SonoVascular Inc.
SonoVascular Inc. and OsteoCure Therapeutics, both based in the Triangle, have been selected for the highly competitive MedTech Innovator (MTI) 2026 Accelerator Cohort, highlighting the depth and momentum of North Carolina’s rapidly growing medtech ecosystem.
The 65 companies selected for the 2026 cohort, representing the top 4% of 1,835 global applications, will participate in MTI’s four-month program designed and proven to de-risk medtech innovation and accelerate the path to U.S. market success. MTI is the world’s largest and most impactful accelerator for medical technology startups.
During the four-month accelerator program, the cohort gains access to MTI’s proprietary platform, mentors, coaches, and a peer network to identify strategies and planning to avoid costly delays and increase the chance of success in raising capital and accessing the U.S. market.
